Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: A randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone

✍ Scribed by W. Bell; J.S. Davies; W.D. Evans; M.F. Scanlon; R. Mullen

• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 124 KB
• Volume: 16
• Category: Article
• ISSN: 1042-0533
• DOI: 10.1002/ajhb.20055